Recombinant albumins containing additional peptide sequences smaller than barbourin retain the ability of barbourin-albumin to inhibit platelet aggregation.
about
Substantially improved pharmacokinetics of recombinant human butyrylcholinesterase by fusion to human serum albumin.Addition of a sequence from alpha2-antiplasmin transforms human serum albumin into a blood clot component that speeds clot lysisIncorporation of albumin fusion proteins into fibrin clots in vitro and in vivo: comparison of different fusion motifs recognized by factor XIIIa.Removal of stabilizers from human serum albumin by adsorbents and dialysis used in blood purification.
P2860
Recombinant albumins containing additional peptide sequences smaller than barbourin retain the ability of barbourin-albumin to inhibit platelet aggregation.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Recombinant albumins containin ...... inhibit platelet aggregation.
@ast
Recombinant albumins containin ...... inhibit platelet aggregation.
@en
type
label
Recombinant albumins containin ...... inhibit platelet aggregation.
@ast
Recombinant albumins containin ...... inhibit platelet aggregation.
@en
prefLabel
Recombinant albumins containin ...... inhibit platelet aggregation.
@ast
Recombinant albumins containin ...... inhibit platelet aggregation.
@en
P2093
P356
P1476
Recombinant albumins containin ...... inhibit platelet aggregation.
@en
P2093
Brianna Wilson
Louise J Eltringham-Smith
Sharon Gataiance
Varsha Bhakta
William P Sheffield
P304
P356
10.1267/THRO05050914
P577
2005-05-01T00:00:00Z